EMBO Molecular Medicine (Feb 2016)

Cardiac‐specific succinate dehydrogenase deficiency in Barth syndrome

  • Jan Dudek,
  • I‐Fen Cheng,
  • Arpita Chowdhury,
  • Katharina Wozny,
  • Martina Balleininger,
  • Robert Reinhold,
  • Silke Grunau,
  • Sylvie Callegari,
  • Karl Toischer,
  • Ronald JA Wanders,
  • Gerd Hasenfuß,
  • Britta Brügger,
  • Kaomei Guan,
  • Peter Rehling

DOI
https://doi.org/10.15252/emmm.201505644
Journal volume & issue
Vol. 8, no. 2
pp. 139 – 154

Abstract

Read online

Abstract Barth syndrome (BTHS) is a cardiomyopathy caused by the loss of tafazzin, a mitochondrial acyltransferase involved in the maturation of the glycerophospholipid cardiolipin. It has remained enigmatic as to why a systemic loss of cardiolipin leads to cardiomyopathy. Using a genetic ablation of tafazzin function in the BTHS mouse model, we identified severe structural changes in respiratory chain supercomplexes at a pre‐onset stage of the disease. This reorganization of supercomplexes was specific to cardiac tissue and could be recapitulated in cardiomyocytes derived from BTHS patients. Moreover, our analyses demonstrate a cardiac‐specific loss of succinate dehydrogenase (SDH), an enzyme linking the respiratory chain with the tricarboxylic acid cycle. As a similar defect of SDH is apparent in patient cell‐derived cardiomyocytes, we conclude that these defects represent a molecular basis for the cardiac pathology in Barth syndrome.

Keywords